Poland· PL-100472218
Gaviscon duo o smaku mięty
A alginic acid product containing natrii alginas + natrii hydrogenocarbonas + calcii carbonas, registered in Poland by Reckitt Benckiser (Poland) S.A.. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Alginic acid is registered in 10 of 19 countries.
Countries holding a registration under ATC A02BX13 (alginic acid), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Alginic acid · ATC A02BX13
10 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Natrii alginas + Natrii hydrogenocarbonas + Calcii carbonas
- Manufacturer
- Reckitt Benckiser (Poland) S.A.
- Country
- Poland (PL)
- ATC code
- A02BX13
- ATC class
- Alginic acid
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 6
- gtin05900627119275
- gtin05900627119268
- gtin05900627119244
- gtin05900627119251
- gtin05900627119299
- gtin05900627119282
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Alginic acid in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsGaviscon 250 mg aardbei, kauwtablettenReckitt Benckiser Healthcare B.V.
- SwitzerlandGaviscon Erdbeer, KautablettenReckitt Benckiser (Switzerland) AG
- SpainGAVISCON COMPRIMIDOS MASTICABLES SABOR FRESAReckitt Benckiser (Romania) S.R.L.
- FranceGAVINIUM MENTHE SANS SUCRE, comprimé à croquer édulcoré à l’aspartam et à l’acésulfame potassiqueRECKITT BENCKISER HEALTHCARE FRANCE
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/31c101c4-de11-444e-b515-e0536fa78be7 GET /v1/drugs/31c101c4-de11-444e-b515-e0536fa78be7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zawiesina doustna",
"source": "urpl",
"strength": "500 mg + 213 mg + 325 mg",
"packaging": "05900627119268 ¦ OTC ¦ 160476\n1 butelka 250 ml\n05900627119275 ¦ OTC ¦ 160477\n1 butelka 300 ml\n05900627119244 ¦ OTC ¦ 160478\n1 butelka 150 ml\n05900627119251 ¦ OTC ¦ 160479\n1 butelka 200 ml\n05900627119299 ¦ OTC ¦ 160480\n1 butelka 600 ml\n05900627119282 ¦ OTC ¦ 160481\n1 butelka 500 ml",
"substance": "Natrii alginas 500 mg/10 ml + Natrii hydrogenocarbonas 213 mg/10 ml + Calcii carbonas 325 mg/10 ml",
"common_name": "Natrii alginas + Natrii hydrogenocarbonas + Calcii carbonas",
"pl_product_id": "100472218",
"pozwolenie_nr": "28943",
"auth_procedure": "DCP",
"authorisation_validity": "2030-03-24"
}See everything about alginic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.